CAJ | 학술논문

目的观察放射性核素89锶(89SrCl2)对骨转移癌的止痛疗效,并总结护理体会.方法各类骨转移癌患者共58例均以同一剂量静脉注射给药,即4mci/人89SrCl2治疗,随访3个月-1年.结果经89SrCl2治疗后总有效率85.89%,未发现严重不良反应.结论89SrCl2治疗骨转移癌疼痛疗效明显,使多数患者的生活质量得以改善,部分患者病灶缩小或消失,起到了缓解病情延长生命的作用,是一种安全有效的方法.
목적관찰방사성핵소89송(89SrCl2)대골전이암적지통료효,병총결호리체회.방법각류골전이암환자공58례균이동일제량정맥주사급약,즉4mci/인89SrCl2치료,수방3개월-1년.결과경89SrCl2치료후총유효솔85.89%,미발현엄중불량반응.결론89SrCl2치료골전이암동통료효명현,사다수환자적생활질량득이개선,부분환자병조축소혹소실,기도료완해병정연장생명적작용,시일충안전유효적방법.
@@@@Objective To observe the analgesic effect of radio nuclides 89Sr(89SrCl2) on bone metastases, and summarize the nursing experience. Methods 58 cases with different bone metastases recieved 89SrCl2 treatment in the same dose (ie 4mci/person) intravenous administration , and the follow-up time was from 3 months to 1 year after treatment. Results After the treatment, the total effective rate was 85.89%, with no serious adverse reactions. Conclusions Treated metastatic bone cancer pain by 89SrCl2 was effective, the majority of the patient's quality of life can be improved. The lesions in bones were shrinked or disappeared in most patients. It played the role of life-prolonging remission of disease, and it is safe and effective treatment.